PortalPublikationenAllogeneic hematopoietic cell transplantation in patients ⩾7...

Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit?

Standard

Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit? / Haen, S P; Pham, M; Faul, C; Dörfel, D; Vogel, W; Kanz, L; Bethge, W A.

in: BLOOD CANCER J, Jahrgang 6, Nr. 7, 08.07.2016, S. e443.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Haen, SP, Pham, M, Faul, C, Dörfel, D, Vogel, W, Kanz, L & Bethge, WA 2016, 'Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit?', BLOOD CANCER J, Jg. 6, Nr. 7, S. e443. https://doi.org/10.1038/bcj.2016.54

APA

Haen, S. P., Pham, M., Faul, C., Dörfel, D., Vogel, W., Kanz, L., & Bethge, W. A. (2016). Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit? BLOOD CANCER J, 6(7), e443. https://doi.org/10.1038/bcj.2016.54

Vancouver

Haen SP, Pham M, Faul C, Dörfel D, Vogel W, Kanz L et al. Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit? BLOOD CANCER J. 2016 Jul 8;6(7):e443. https://doi.org/10.1038/bcj.2016.54

Bibtex

@article{22fc58771cab46e6b0a62c658a448cf5,
title = "Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit?",
keywords = "Age Factors, Aged, Comorbidity, Female, Graft vs Host Disease/epidemiology, Hematologic Neoplasms/diagnosis, Hematopoietic Stem Cell Transplantation/adverse effects, Humans, Male, Prognosis, Retrospective Studies, Risk Assessment, Survival Rate, Transplantation, Homologous/adverse effects, Treatment Outcome",
author = "Haen, {S P} and M Pham and C Faul and D D{\"o}rfel and W Vogel and L Kanz and Bethge, {W A}",
year = "2016",
month = jul,
day = "8",
doi = "10.1038/bcj.2016.54",
language = "English",
volume = "6",
pages = "e443",
journal = "BLOOD CANCER J",
issn = "2044-5385",
publisher = "NATURE PUBLISHING GROUP",
number = "7",

}

RIS

TY - JOUR

T1 - Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit?

AU - Haen, S P

AU - Pham, M

AU - Faul, C

AU - Dörfel, D

AU - Vogel, W

AU - Kanz, L

AU - Bethge, W A

PY - 2016/7/8

Y1 - 2016/7/8

KW - Age Factors

KW - Aged

KW - Comorbidity

KW - Female

KW - Graft vs Host Disease/epidemiology

KW - Hematologic Neoplasms/diagnosis

KW - Hematopoietic Stem Cell Transplantation/adverse effects

KW - Humans

KW - Male

KW - Prognosis

KW - Retrospective Studies

KW - Risk Assessment

KW - Survival Rate

KW - Transplantation, Homologous/adverse effects

KW - Treatment Outcome

U2 - 10.1038/bcj.2016.54

DO - 10.1038/bcj.2016.54

M3 - SCORING: Journal article

C2 - 27391575

VL - 6

SP - e443

JO - BLOOD CANCER J

JF - BLOOD CANCER J

SN - 2044-5385

IS - 7

ER -